(Q37387037)

English

Ipilimumab: controversies in its development, utility and autoimmune adverse events.

scientific article published on 06 February 2009

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit